
AHR Stock Forecast & Price Target
AHR Analyst Ratings
Bulls say
American Healthcare REIT Inc. is positioned for significant growth potential through 2026 and 2027, driven by an anticipated increase in acquisition activity, with an expected additional $600 million in 2026. The company is benefiting from strong performance in its Trilogy-operated units, which are experiencing healthy growth due to favorable industry trends and an improved skill mix, projected to yield a two-year compound annual growth rate (CAGR) of 11.8% for Trilogy and 15.5% for SHOP. With a superior cost of capital since late 2024, American Healthcare REIT is in a strong position to capitalize on external growth opportunities, enhancing its ability to deploy capital efficiently.
Bears say
American Healthcare REIT faces a negative outlook primarily due to the significant risks associated with its tenant performance, particularly in regions experiencing economic challenges or regulatory changes that could adversely affect rental income. The reliance on skilled nursing facilities for nearly half of the company's net operating income (NOI) introduces heightened volatility, making the REIT vulnerable to fluctuations in both tenant financial health and broader market conditions. Additionally, potential headwinds related to capital market volatility, rising construction costs, and increased competition may hinder the company’s ability to meet organic NOI growth expectations, further impacting its earnings potential.
This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.
AHR Analyst Forecast & Price Prediction
Start investing in AHR
Order type
Buy in
Order amount
Est. shares
0 shares